{"cdcTestId":"2015-0019","testcaseName":"Zoster: MMR to Zoster interval 28 - 1 days","vaccineGroup":"ZOSTER","evaluationTestType":"Live Virus: Below Minimum","forecastTestType":"Recommended based on minimum interval from live virus vaccine","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1971-09-22T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-22T00:00:00","vaccineName":"M-M-R II","cvx":"03","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ZOSTAVAX","cvx":"121","mvx":"MSD","evaluationStatus":"Not Valid","evaluationReason":"Live Virus Conflict"}]},"forecast":{"forecastNum":"1","earliestDate":"2022-12-14T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-09-22T00:00:00","vaccineName":"M-M-R II","cvx":"03","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ZOSTAVAX","cvx":"121","mvx":"MSD","evaluationStatus":"Not Valid","evaluationReason":"Live Virus Conflict"}],"dateAdded":"2015-06-23T00:00:00","dateUpdated":"2018-04-19T07:33:57.577","generalDescription":"This test case describes when a patient is in early 50\u0027s and is administered a Zoster vaccine dose 28 -1 days after a MMR vaccine dose that the ZVL (Zostavax) vaccine dose is considered invalid. Zoster should be forecast in the future.","changedInVersion":"3.4","reasonForChange":"V3.4: Updated test case to reflect updated Zoster recommendations for Shingrix.\nV2.0: New test case for version 2.0 which expanded scope into Adult recommendations"}